Bandingkan Harga & Kinerja Martina Berto Tbk. (MBTO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Martina Berto Tbk. dan Organon Pharma Indonesia Tbk.: Martina Berto Tbk. diperdagangkan di Rp168 (kapitalisasi pasar 150,87 M, volume 24 jam 147,57 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Martina Berto Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| MBTO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 150,87 M | 104,4 M |
Volume | 147,57 jt | — |
Lot | 1,48 jt | — |
Perputaran | 24,01 M | — |
Harga Rata-rata | 162,68 | — |
Nilai Transaksi | 24,01 M | — |
Harga Ekuilibrium Indikatif | 168 | — |
Volume Ekuilibrium Indikatif | 76,3 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Martina Berto Tbk.
PT Martina Berto Tbk (the Company) was established in the Republic of Indonesia on 1 June 1977 based on Notarial deed No. 9 of Poppy Savitri Parmanto, S.H. In 1977, PT Matina Berto stands as a home industry with product branded Sariayu. In 1981, the company established the first modern factory on Pulo Ayan, Pulogadung Industrial Estate. In 1986, the second factory was established on Pulo Kambing, Pulogadung Industrial Estate. In 1993, the company acquired cosmetics factory PT Cedefindo as contract manufacturing for internal & external. In 1995, PT Martina Berto III was established in Gunung Putri, Bogor.The Company’s articles of association has been amended several times, most recently by notarial deed No.9 of Yanto W, S.H., dated Sep 27 2010, concerning among others, change in par value, and public offering.
Selengkapnya di halaman MBTO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
